As one of the leading health research institutes in Canada, Lawson has many stories to tell. Search through our Latest News to find out about important medical breakthroughs, major announcements and research publications, new clinical trials, industry partnerships, commercialization developments and more.
Our Events calendar includes a variety of research, industry and foundation listings You can also find out more about Lawson’s signature events:
Bill Dickie, President and CEO of Advanced Accelerator Applications (AAA) Canada Inc., accepts the 2017 Industry Partner of the Year Award on behalf of IDB Holland bv, an AAA company.
IDB Holland bv is a Health Canada authorized supplier of Lutetium-177 (Lu-177). Lu-177 is a nuclear medicine treatment used to improve the quality of life in patients with neuroendocrine cancer.
With over 45 of years of philanthropic leadership, Helen and Andy Spriet have significantly advanced hospital-based research and patient care in London, Ontario. Their support of health research through the St. Joseph’s Health Care Foundation has enabled innovation and discovery in the areas of urology, mobility and aging, prostate cancer, retina disease, geriatric care, spinal cord injury and surgical mechatronics.
The Cardiac Rehabilitation and Secondary Prevention program at St. Joseph’s Health Care London, in collaboration with London Health Sciences Centre’s Cardiac Care Program is launching a new initiative to increase the engagement of patients with common heart rhythm conditions.